Patient Care And Monitoring

© The frequency offollow-up visits for patients with hypertension will vary based on individual cases, but will be influenced by severity of hypertension, comorbidities, and choice of agent selected. A recent analysis of the VALUE trial found that achieving BP control within 6 months reduced CV events compared to a longer time to achieve goal. In addition, another recent analysis of the INSIGHT trial found that the more times a patient is below goal, the lower the risk.94,95 These studies suggest that there is an urgency to achieve and maintain BP control, and this may necessitate frequent assessment and adjustments (i.e., 2 weeks). At a minimum, assessment of response to medications should be done at 1-month intervals.1 In patients with stage 2 hypertension or those with comorbidities (e.g., diabetes, vascular disease, CHF, or CKD),

shorter time frames of 2 weeks or less are more appropriate. Once BP is controlled, annual or semiannual monitoring for changes in serum biochemistries such as serum creatinine or potassium are recommended.1 However, for patients with CHF, CKD, or diabetes, more frequent monitoring will be necessary to adequately control comor-bid conditions. Another aspect to monitoring relates to the importance of medication adherence. Confirmation of continued use of antihypertensive medications should be considered in the routine monitoring of patients on numerous medications for hypertension. Evaluation of side effects, lab abnormalities, and/or progression to target organ damage should also be considered at appropriate intervals. Given the generally asymptomatic nature of hypertension, patient motivation to adhere to prescribed medications becomes a key tool in controlling hypertension.

Given the chronic nature of hypertension, parsimony of medication regimens is a virtue of a good therapeutic plan. Minimizing the number of medications a patient is required to take has the potential to enhance adherence and mitigate cost. Often, control of BP is achieved by use of two or even three or more BP lowering medica-tions.34,96 Many combination products contain a diuretic as one of their active components. However, combination therapy may limit the ability of the clinician to titrate the dose of a specific agent. As such, the number of medications ("pill count") may often be reduced through use of combination products. This inherently simplifies the number of medications and copays a patient may have to endure to achieve effective BP control. These practicalities, although obvious, go a long way to optimize adherence, another challenge to maximizing therapy effectiveness.

How To Deal With Rosacea and Eczema

How To Deal With Rosacea and Eczema

Rosacea and Eczema are two skin conditions that are fairly commonly found throughout the world. Each of them is characterized by different features, and can be both discomfiting as well as result in undesirable appearance features. In a nutshell, theyre problems that many would want to deal with.

Get My Free Ebook


Post a comment